A safety and tolerability study of differently-charged nanoparticles for local pulmonary drug delivery
- Institute for Drug Research, Hebrew University of Jerusalem, Jerusalem, 91120 (Israel)
- Beth Israel Deaconess Medical Center, Division of Viral Pathogenesis, Harvard Medical School, Boston, MA 02215 (United States)
- Institute of Pulmonology, Hadassah-Hebrew University Medical Center, Jerusalem, 91120 (Israel)
- Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, 91120 (Israel)
- School of Pharmacy, Hebrew University of Jerusalem, Jerusalem, 91120 (Israel)
- Fraunhofer Institute of Toxicology and Experimental Medicine, Nikolai Fuchs Strasse 1, 30625 Hannover (Germany)
Nanoparticle (NP) based drug delivery systems provide promising opportunities in the treatment of lung diseases. Here we examined the safety and tolerability of pulmonary delivered NPs consisting of PEG-PLA as a function of particle surface charge. The rationale for such a comparison should be attributed to the differential pulmonary toxicity of positively and negatively charged PEG-PLA NP. Thus, the local and systemic effects of pulmonary administered NPs were investigated following 5 days of daily endotracheal instillation to BALB/c mice that were euthanized on the eighth or nineteenth day of the experiment. We collected bronchoalveolar lavages and studied hematological as well as histochemistry parameters. Notably, the cationic stearylamine based PEG-PLA NPs elicited increased local and systemic toxic effects both on the eighth and nineteenth day. In contrast, anionic NPs of similar size were much better tolerated with local inflammatory effects observed only on the eighth experimental day after pulmonary instillation. No systemic toxicity effect was observed although a moderate change was noted in the platelet count that was not considered to be of clinical significance. No pathological observations were detected in the internal organs following instillation of anionic NPs. Overall these observations suggest that anionic PEG-PLA NPs are useful pulmonary drug carriers that should be considered as a promising therapeutic drug delivery system.
- OSTI ID:
- 21451174
- Journal Information:
- Toxicology and Applied Pharmacology, Vol. 246, Issue 1-2; Other Information: DOI: 10.1016/j.taap.2010.04.011; PII: S0041-008X(10)00138-9; Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; ISSN 0041-008X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Inflammatory effects of inhaled sulfur mustard in rat lung
Comparative toxicity of size-fractionated airborne particulate matter obtained from different cities in the United States